The Future of Clinical Trials: AI and Machine Learning Applications
The Paradigm Shift: From Manual Protocols to Intelligent Systems The traditional clinical trial model, largely unchanged for decades, is characterized by immense cost, protracted timelines, and high failure rates. A staggering 90% of drug candidates fail during clinical development, with nearly 50% faltering in Phase III trials after significant investment. This inefficiency stifles innovation and …